Thyroid Gland Carcinoma clinical trials at UCSF
2 in progress, 1 open to eligible people

• Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

  open to eligible people ages 18 years and up

  This pilot clinical trial studies how well Gallium-68 prostate specific membrane antigen positron emission tomography (PET) work in diagnosing patients with thyroid cancer. Diagnostic procedures, such as 68Ga-PSMA PET, may more accurately diagnose thyroid cancer and find out how far the disease has spread.

  San Francisco, California

• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

  Sorry, in progress, not accepting new patients

  This phase I trial studies the side effects and best dose of cabozantinib S-malate in treating younger patients with solid tumors that have come back or no longer respond to treatment. Cabozantinib S-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

  San Francisco, California and other locations

Last updated: August 27, 2019